Q4 2024 Management View CEO Rick Matros highlighted that Sabra delivered consistent strong performance in Q4 2024, with senior housing and skilled nursing portfolios showing improvement. SHOP same-store occupancy increased by 80 basis points sequentially,

Truist Financial analyst Michael Lewis maintained a Hold rating on Sabra Healthcare REIT (SBRA – Research Report) today. The company’s shares

Although the revenue and EPS for Sabra (SBRA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Sabra Health Care REIT, Inc. ( NASDAQ: SBRA) Q4 2024 Earnings Conference Call February 20, 2025 1:00 PM ET Lukas Hartwich - EVP, Finance Rick Matros - CEO, President & Chair Talya Nevo-Hacohen - CIO, Treasurer & EVP Mike Costa - CFO

Commenting on the fourth quarter’s results, Rick Matros, CEO and Chair, said, “We are proud of our results for the year, which reflect the

Sabra (SBRA) delivered FFO and revenue surprises of 0% and 0.48%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

The health care real estate investment trust, based in Tustin, California, posted revenue of $182.3 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected $183.2 million. Sabra expects full-year funds from operations in the range of $1.48 to $1.51 per share.